BCPC joins others in taking the sting out of the Buglife report    qrcode

FavoritesPrint
Forward
Apr. 16, 2010


BCPC has joined with others in the crop protection industry, in writing to the Secretary of State The Rt Hon Hilary Benn MP to oppose the ban on neonicotinicide seed treatments. In September 2009, the environmental organisation Buglife issued a report calling for a ban on the outdoor use of a number of seed treatments but the industry believes the report is flawed in a number of respects.

"There is clear evidence that bee health is a serious cause for concern”, warns Dr Ruscoe, chairman BCPC, “However, contrary to the Buglife report, there is no basis to suggest neonicotinoid seed treatments are having an effect on bee health. In fact the general consensus among scientists, regulators and bee keepers is that high levels of disease and parasitic mites such as Varroa are having the greatest impact on bee populations. If anti-pesticide groups, backing the Buglife report, continue to claim there is a link between a decline in the bee population and insecticidal seed treatments it will deflect resources and research efforts away from the main issues.”

Studies carried out in France, Germany and the US have concluded that there is no correlation between health and the correct use of seed treatments. If there is a ban on these highly effective seed treatments the result could be crop failure due to pest attack, and an increase in the use of other broad-spectrum insecticides.

"We at BCPC have welcomed Defra’s allocation of £4.3million into bee health research and will certainly support a co-ordinated research programme in the UK to identify the causes of declining bee health and find solutions to improving colony survival and safeguarding an essential pollinator,” concludes Dr Ruscoe.  
 

Source: BCPC News

Recommended Events

Popular speakers

Bill Duan

General Manager

Leili Marine BioIndustry INC.

Li Qian

Biocontrol product development manager

Syngenta Biologicals

Romy Ursúa Monreal

CEO

IKAN Consultores

Romy is a regulatory and legal expert with more than 13 years of experience in Mexico’s crop protection and biologicals industry. As CEO of IKAN Consultores, part of the LATAM Regulatory Network, she defines the firm’s strategic vision and leads the development of regulatory and compliance strategies that help national and international clients achieve market access and regulatory alignment across Latin America. She also serves as Chair of the Crop Protection Commission at the Mexican Association of Professionals in Health Regulation (AMEPRES). Her leadership has positioned IKAN as a strategic partner for national and international companies seeking to operate within complex regulatory frameworks in Mexico and Latin America. Romy holds a Law degree, postgraduate studies in Administrative and Health Law, and a diploma in Customs Administration from Tecnológico de Monterrey, strengthening her focus on trade, regulatory compliance, and customs management.

Dr. Rao Chitong

Partner and Chief Scientist

Bluepha

• Bachelor of Science in Biology, Peking University; Ph.D. in Microbiology, University of Toronto; Postdoctoral Fellow in Microbiome Research, Harvard Medical School. • Published over 20 papers in top-tier international journals such as Natureand Cell. • Awarded the 2021 National Award for Outstanding Self-Financed International Students. • Recipient of the 2021 Distinguished Research Award from the Chinese Scholars and Experts Association at Harvard Medical School. • Awarded the 2022 National-Level Overseas Young Talents Project; previously served as an Associate Professor at the Health Science Center of Peking University before joining Bluepha as a full-time Chief Scientist. • Recipient of the 2023 Shanghai Magnolia Talent Program. • Awarded the 2024 Shanghai Science and Technology Rising Star Program.